“We are so proud to have received Best Fertility Centre for the 8th year as it recognizes the level of care we strive to provide for our patients,” says Olive Fertility co-director, Dr. Beth Taylor. “The fact that Olive Fertility has among the best pregnancy success rates in Canada is due to our lab, our team of fertility experts and outstanding staff. Everyone at Olive, from the receptionists at the front desk, to the patient-care coordinators, the nurses, the embryologists, and the doctors, strive to make sure that patients have the best experience possible.”
The rate of infertility in Canada has doubled over the last 20 years according to a Stats Canada report, and Olive Fertility has seen a surge of over 30% in the demand for fertility treatment and egg freezing since the pandemic.
“We recommend that anyone over 35 should have a full fertility workup if they haven’t conceived after six months of unprotected intercourse,” says Dr. Taylor. “Age is an important factor, so we want to get a full picture of a person’s fertility soon and then start treatment without delay.”
Recent advances in fertility treatment and preimplantation genetic testing have improved the chances of achieving a pregnancy and having a healthy baby for individuals and couples.
Fertility evaluation and most testing is covered by MSP in British Columbia with a referral from a family physician or a doctor at a walk-in clinic.
Olive would also like to congratulate Acubalance Wellness Centre for receiving the BOV award for Best Naturopathic Clinic. Well done!
Olive Fertility Centre (olivefertility.com) is one Canada’s leading fertility centres with clinics in Vancouver, Surrey, Victoria, and Kelowna offering an award-winning IVF lab, personal care teams, and innovative programs including specialized genetic testing, egg freezing, and prenatal NIPT testing.
Media Contact
Mairi Campbell, Personae Concepts, 1 7788855300, [email protected], Personae Concepts
NORTH BETHESDA, Md., Sept. 7, 2023 /PRNewswire-PRWeb/ — The International Society for Pharmaceutical Engineering (ISPE) is pleased to announce the results of our 2023–2024 International Board of Directors election. The election was run by an independent third party, Intelliscan, Inc., which provided ISPE with the final audited results.
The Board is responsible for the governance and strategic direction of the Society and will assume their elected positions at the 2023 ISPE Annual Meeting & Expo, taking place in Las Vegas, NV, USA, and virtually from 15–18 October. The following pharmaceutical industry leaders have been elected to positions on the 2023–2024 ISPE International Board of Directors.
Officers:
Chair: Scott W. Billman, Vice President, Engineering, Pharmaceutical Services, Thermo Fisher Scientific
Vice Chair: Jeffrey A. Biskup, PE, Executive Board Chairman/Co-Founder, CRB
Treasurer: Vivianne J. Arencibia, Vice President, Global Quality Systems and Compliance, Moderna
Secretary: Ylva Ek, Founder, Robur Life Science Advisory AB
Past Chair: Michael L. Rutherford, Executive Director, Computer Systems Quality & Data Integrity, Syneos Health
Ex Officio Non-voting Member: Thomas B. Hartman, President and CEO, ISPE
Directors Elected to a Second Term:
Sarah C. Pope Miksinski, PhD, Executive Director, CMC Regulatory Affairs, Gilead Sciences
Georg Singewald, PhD, Senior Vice President, Global Head of Engineering, Technology & Sustainability, Roche / Genentech
Timothy J.N. Watson, PhD, Vice President – Head of CMC Regulatory Affairs, Gilead Sciences
New Director:
Liz M. Dooley, MSc, Senior Director Global Engineering & Technology, Johnson & Johnson
Continuing Board Members:
The following Directors were elected in 2022 to serve a two-year term and will continue their service on the Board.
Nina S. Cauchon, PhD, Director Regulatory Affairs – CMC, Amgen Inc.
David Churchward, Global Head Sterility Assurance, Cell and Gene Technologies, Lonza Biologics
Norman A. Goldschmidt, President, Genesis AEC
Michael Martin, CEO, CAI
Teresa Minero, Founder & CEO, LifeBee – Digitalizing Life Sciences
Hirofumi Suzuki, PhD, Product Supply Japan, Head of Product Supply Coordination, Bayer Yakuhin Ltd.
The following individuals will complete their Board service and end their term at the 2023 ISPE Annual Meeting & Expo. ISPE thanks these individuals for their dedication and commitment to the organization.
Jörg Zimmermann, Vice President Vetter Development Service External Affairs, Vetter Pharma Fertigung GmbH & Co KG
Zen-Zen Yen, Head of Engineering, Bayer AG
Visit ISPE Board of Directors Election Results and delve into comprehensive biographies of all the esteemed members of the ISPE’s International Board of Directors.
About ISPE The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 20,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.
Grants for the year ahead have been awarded in the form of two Post-Doctoral Fellowships, seven Research Grants, two Diversity in Parkinson’s Disease Research grants, eight APDA Centers for Advanced Research, and one George C. Cotzias Memorial Fellowship, APDA’s most prestigious award.
For the fourth year in a row, APDA is awarding a specialized grant to two researchers focused on diverse and under-represented communities. APDA created the first-of-its-kind Diversity in Parkinson’s Disease Research Grant in 2019 to encourage and support researchers who are committed to diversity-focused research so we can learn more about how the disease affects different populations and ultimately better serve people with PD from all communities.
All APDA grants are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board (SAB) which is comprised of scientists with a wide array of backgrounds and expertise in all areas relevant to PD research. The SAB meets annually to review all grant proposals and set the scientific direction of APDA’s annual research investment. “Once again our Scientific Advisory Board reviewed many excellent applications and had to make difficult decisions about whom to fund” states Rebecca Gilbert, MD, PhD, and Chief Scientific Officer, APDA. “I am very proud of the many promising projects that we are funding this year.”
The George C. Cotzias Fellowship is APDA’s most prestigious grant and is awarded to a young physician-scientist with exceptional promise who is establishing a career in research, teaching, and clinical services relevant to Parkinson’s. The award spans three years and is designed to fund a long-range project focused on PD. This year’s awardee is:
Krithi Irmady, MD, PhD — The Rockefeller University, New York, NY
RNA regulation in Parkinson’s disease and levodopa-induced dyskinesia
APDA Diversity in Parkinson’s Disease Research Grants are one-year grants to study the health inequities and/or differences among under-studied PD communities, across the spectrum of ethnicity, ancestry, geography, socioeconomic conditions, and gender. This year’s awardees are:
Low utilization of deep brain stimulation (DBS) therapy among minoritized individuals with Parkinson’s disease
Physical activity among Latino/a people with Parkinson’s disease and their care partners
Post-Doctoral Fellowships are awarded to support post-doctoral scientists who recently completed their PhD work and whose research holds promise to provide new insights into the pathophysiology, etiology, and treatment of PD. This year’s awardees are:
The neurobiological basis of Parkinson’s disease clinical subtypes
Enhancing neuronal resilience to neurodegeneration via the epigenetic-metabolic axis
Research Grants are awarded to investigators performing innovative PD research at major academic institutions across the United States. This year’s awardees are:
Investigating the role of progranulin in synucleinopathy
Cdk5 inhibition as a protective mechanism against environmental toxicant induced Parkinson’s disease
Mechanisms of SARS-CoV-2 infection induced dopamine neuron damage
Enrico Opri, PhD — The Regents of the University of Michigan, Ann Arbor, MI
Stimulation induced evoked potentials for guided intra and post-operative functional mapping
Using IPSC models to interrogate Inflammasome-mediated pathogenesis in Parkinson’s Disease
The role of Lamp1 in age-related neurodegenerative diseases
Mechanisms of posterior cortical circuit dysfunction and cognitive impairment in a mouse model of PD
In addition, continued funding was granted for eight APDA Centers for Advanced Research to support various programs including research trainees, clinical fellowship programs, early-stage discovery programs and later-stage clinical translation. These Centers facilitate research that is at the forefront of investigation into the causes, treatments and ultimately the cure for PD. The current APDA Centers for Advanced Research are:
Boston University School of Medicine, Boston, MA
Emory University School of Medicine, Atlanta, GA
Mayo Clinic, Jacksonville, FL
Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
The Brigham and Women’s Hospital, Boston, MA
University of Alabama at Birmingham School of Medicine, Birmingham, AL
University of Pittsburgh Medical Center, Pittsburgh, PA
Washington University School of Medicine, St. Louis, MO
“We are confident that the projects that we are currently funding will have a high impact on further understanding Parkinson’s disease,” states Chambers. “This work is only possible because of the support of our generous APDA donors.”
Researchers and physicians who are interested in applying for APDA funding can visit http://www.apdaparkinson.org/research for details on the 2024-2025 funding opportunities. Letters of Intent for the 2024-2025 grant cycle can be submitted starting September 28, 2023, with a deadline of December 2, 2023.
Those who want to support APDA’s critical research with a donation can do so by visiting http://www.apdaparkinson.org/donate or mailing a check payable to APDA to: APDA, PO Box 61420, Staten Island, NY 10306.
The American Parkinson Disease Association (APDA) is a nationwide grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to help the approximately one million people in the United States with PD live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $252 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease. To join us in the fight against Parkinson’s disease and to learn more about the support APDA provides nationally through our network of Chapters and Information & Referral (I&R) Centers, as well as their national Research Program and Centers for Advanced Research, please visit http://www.apdaparkinson.org.
In Canada, a spat has broken out between the Canadian Association of Physicians for the Environment (CAPE) and Indigenous entrepreneurs over the development of Liquified Natural Gas (LNG). CAPE was funded for $492,000 by the McConnell Foundation for a climate campaign; McConnell previously contributed $10 million in 2017 to BlackRock’s Global Renewables Power Fund II. An Aug. 28, 2023, piece in The Hill Times has CAPE members attacking pro-LNG Indigenous groups as proxies for industry. In the Sept. 02, 2023, National Post, policy analyst Melissa Mbarki, policy analyst with the Macdonald Laurier Institute writes that “Trudeau’s net-zero policy violates UNDRIP*, poverty reduction strategy; Indigenous communities are developing energy to address their well-being.” (*United Nations Declaration of Rights for Indigenous Peoples)
In June 2023, the Canadian government’s Justice department issued its UNDRIP Action Plan which calls for a large scale rewriting of all Canadian law to align with UNDRIP. However, as Mbarki points out, Canada’s commitment to NetZero targets conflict with its UNDRIP obligations and promises to enhance the lives of Indigenous people and have them lead economic activities like resource development. Friends of Science says NetZero is a “Holy Grail.“
These issues will be heightened in September, not only due to climate conferences and marches but also the UN Special Rapporteur on Indigenous Human Rights is set to release his report about Canada at the UN Human Rights Council. China has accused Canada of genocide; the outcome of the Special Rapporteur’s report may have significant geopolitical impact on Canada, turning it from a wannabe climate leader to a global pariah.
The climate crisis platform is rapidly collapsing. Climate scientist Patrick Brown revealed in a Sept. 5, 2023 essay in The Free Press, that in order to get published in Nature, he distorted the facts about wildfire. Brown states: “To put it bluntly, climate science has become less about understanding the complexities of the world and more about serving as a kind of Cassandra, urgently warning the public about the dangers of climate change. However understandable this instinct may be, it distorts a great deal of climate science research, misinforms the public, and most importantly, makes practical solutions more difficult to achieve.”
Three new research papers show that recent warming is likely predominantly naturally caused, thus the NetZero targets and persistent demonization of oil, natural gas and coal are misdirected, and large amounts of public funds are being wasted, says Friends of Science Society.
Connolley et al (2023) assesses Northern Hemisphere surface temperature trends since 1850, finding that it is not clear whether warming is human-caused, natural or a bit of both. Soon et al (2023) examines Northern Hemispheric land component of global surface temperatures since this is the most data-rich component, finding that urban heat island effect creates a significant bias effect in temperature measurements. Katata et al (2023) finds that urbanization bias could account for ~20% of the long-term warming.
Friends of Science Society is calling upon people to “Break Free from Climate Tyranny: Evidence Over Ideology.” A recent Friends of Science video discusses the value of The Scientific Method as a means of finding useful knowledge.
About
Friends of Science Society is an independent group of earth, atmospheric and solar scientists, engineers, and citizens that is celebrating its 21st year of offering climate science insights. After a thorough review of a broad spectrum of literature on climate change, Friends of Science Society has concluded that the sun is the main driver of climate change, not carbon dioxide (CO2). Friends of Science Society PO Box 61172 RPO Kensington Calgary AB T2N 4S6 Canada Toll-free Telephone: 1-888-789-9597 Web: friendsofscience.org E-mail: contact(at)friendsofscience(dot)org Web: climatechange101.ca
The inaugural year of this event was 2014 for the the Clearwater, Florida based periodontal practice. Many others in the community have helped out each year since then. Dr. Britten stated, “Having local dentists involved enables us to provide more comprehensive care to our veterans. Being a periodontist, my specialty is really the surrounding structures of the teeth; roots, gum and bone. My job is to help with the foundation. Having restorative specialists involved helps us to treat the whole mouth and really deliver comprehensive care to these veterans.”
“This year’s event filled up right away again!” Said a staff member at Britten Periodontics. “We look forward to greeting veteran’s, old friends and new, for this year’s event.”
Britten Periodontics & Implant Dentistry is a periodontal practice offering patients personalized dental care in implant dentistry in Clearwater, Florida. Dr. Todd Britten offers sedation dentistry. For more information, visit https://brittenperio.com
NEW YORK, Sept. 6, 2023 /PRNewswire/ — The Global orthodontic market is expected to grow by USD 8.39 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 17.13% during the forecast period, according to Technavio Research. North America is…
At Options, the care team of licensed medical providers and health coaches work together to create customized weight loss plans tailored to patients’ individual needs, aspirations, and lifestyles. Not only does this approach help patients achieve weight loss success, but it also provides invaluable education, guidance, and support needed to manage a healthy weight for years to come.
The Fishers comprehensive care team is honored to bring a new standard of compassionate medical weight loss care to Central Indiana individuals looking to lose weight and improve their overall health. The clinic cordially invites the communities of Noblesville, Saxony Village, Hamilton Proper, Pendleton, Lawrence, and surrounding communities to join in celebrating the clinic’s soft opening from September 12th–18th with savings of up to 40% on weight loss programs. The clinic’s official ribbon-cutting will occur on September 26th at 11 a.m., with exclusive sales taking place throughout the week.
Options’ comprehensive approach to weight loss is what makes it different. “At Options, we’re approaching weight loss and wellness from all angles. We are equipping you with the knowledge to make empowered decisions and take ownership of the path to freedom that you carve out ahead. You will never walk out of our clinic with a meal or medications and be left to figure it out on your own. We position each patient with a team of specialists that rally around you and hold your hand from beginning to end,” said Dr. Katrina Mattingly, Chief Medical Officer of Options Medical Weight Loss.
Learn what makes Options Medical Weight Loss different in this short video.
Patients can start their journey by signing up for a free consultation and metabolic scan on our‥website, or by calling 888-405-LOSE (5673).
About Options Medical Weight Loss:
Options Medical Weight Loss was founded in 2014 in Chicago, Illinois, and has since opened locations throughout Illinois, Ohio, Florida, Arizona, and now Indiana, with continued plans to expand to more states. Options Medical Weight Loss has helped more than 25,000 patients achieve their weight loss goals.
To learn more about the new Fishers Medical Weight Loss Clinic, click here.
SAN FRANCISCO, Sept. 6, 2023 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced that it will host a virtual investor and analyst event on Wednesday, September 13, 2023 at 11:00 a.m. EST / 8:00 a.m. PST to discuss the final Phase 1b data of rezpegaldesleukin (REZPEG) in…
The dynamics of the triple-negative breast cancer market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incremental healthcare spending across the world, and the expected launch of emerging therapies…
The Neo-Pure pasteurization process enables BCFoods to achieve a 99.999% (5-log) reduction of pathogens such as Salmonella and E. coli without compromising food quality. It works by misting a patented blend of organic actives onto food in a continuous flow to inactivate pathogens and reduce total plate count. Since Neo-Pure does not rely on heat, steam, chemical fumigation, or irradiation, Neo-Pure Pasteurized (NPP) foods maintain food integrity, meaning the natural sensory quality, nutrition, and shelf life remain unchanged, just as nature intended.
“The partnership between Agri-Neo and BCFoods sets a new food safety standard in the Chinese dehydrated vegetable and spice market,” said Robert Wong, President of Agri-Neo. “Agri-Neo’s innovation in food safety combined with BCFoods’ global footprint and recognition will immediately impact the global ingredients market. Furthermore, this partnership strengthens our leadership in food safety for the dehydrated vegetable and spice industry. China is one of the largest origin countries for many ingredients such as dehydrated onion and garlic. We are thrilled to work with BCFoods to expand the Neo-Pure Pasteurized (NPP) product portfolio in China.”
BCFoods will be highlighting and sharing information about Neo-Pure Pasteurized (NPP) products at SupplySide West 2023 in Las Vegas in October.
About Agri-Neo The Agri-Neo mission is to help safely feed the world by creating technology that sets new food safety standards. Neo-Pure™, developed by Agri-Neo, eliminates harmful pathogens such as Salmonella, E. coli, and Listeria while maintaining the nutrition and quality that flourishes naturally in food. Agri-Neo has a dedicated team of food scientists, researchers, and engineers to launch more food safety solutions for many high-risk food groups in the future. For more information, visit www.agri-neo.com.
About BCFoods BCFoods has been in the dehydrated vegetable and spice industry since 1978 and has manufacturing plants, distribution facilities and sales offices worldwide. BCFoods offers an extensive selection of premium food ingredients to the industrial ingredient markets that are consistent, affordable, and safe. BCFoods is firmly committed to sustainability and innovation, placing particular emphasis on vertical integration and delivering customized solutions to meet the needs of its customers.
